USANA Health Sciences, Inc. (USNA) News

USANA Health Sciences, Inc. (USNA): $63.75

-0.29 (-0.45%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

A

Add USNA to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#2 of 7

in industry

Filter USNA News Items

USNA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

USNA News Highlights

  • USNA's 30 day story count now stands at 7.
  • Over the past 23 days, the trend for USNA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about USNA are BEAT and SAVE.

Latest USNA News From Around the Web

Below are the latest news stories about USANA HEALTH SCIENCES INC that investors may wish to consider to help them evaluate USNA as an investment opportunity.

Kevin Guest Shares Insights for June Effective Communications Month

In recognition of National Effective Communications Month in June, USANA Health Sciences Chairman and CEO Kevin Guest shares his admiration for the power of effective communication in business and personal life.

Yahoo | June 1, 2023

USANA partners with Promise2Live for global suicide prevention campaign

More than 800,000 people take their life by suicide each year around the world and it is the second leading cause of death for people 10­–34 years old. These sobering numbers are evidence of a global mental health crisis. As an international company focused on health and wellness, USANA has made the promise to stop the stigma, start conversations, and save lives by partnering with Good Deed Revolution and their Promise2Live campaign.

Yahoo | May 30, 2023

Investors in USANA Health Sciences (NYSE:USNA) have unfortunately lost 47% over the last five years

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Yahoo | May 30, 2023

Utah Company Brings Home Five Awards from Local Organization

USANA, a leader in global nutrition, was honored at the Best of State Gala in Salt Lake City, Utah, for its excellence in product quality and innovation. The company brought home prominent awards for its manufacturing department, Celavive, Rev3 Energy, CellSentials, and its Nutritional product line.

Yahoo | May 25, 2023

USANA Executive Director honored at Utah event

USANA is proud to announce Executive Director of Research and Development Rachel Brewer, Ph.D., as one of Utah Business magazine's 30 Women to Watch. The award recognizes the state's movers and shakers who are starting, managing, growing, or otherwise furthering the work of their companies—enhancing Utah's future with a strong female impact.

Yahoo | May 24, 2023

USANA Releases 2022 Sustainability Report

As a global leader in health and wellness, USANA strives to do its part in caring for the planet and its inhabitants. And with a focus on positive business practices, USANA recently released its third annual sustainability report. This high-level review of USANA's 2022 sustainability efforts and progress includes organizational priorities based on a comprehensive stakeholder assessment.

Yahoo | May 22, 2023

USANA Health Sciences (NYSE:USNA) Has Some Difficulty Using Its Capital Effectively

What financial metrics can indicate to us that a company is maturing or even in decline? When we see a declining return...

Yahoo | May 9, 2023

USANA Health Sciences Announces Plans to Expand into India

SALT LAKE CITY, May 04, 2023--USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets.

Yahoo | May 4, 2023

Kevin Guest Shares 5 Secrets for National Recommitment Month of May

Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), shares five steps to stay on track during May's National Recommitment Month.

Yahoo | May 2, 2023

All You Need to Know About USANA Health (USNA) Rating Upgrade to Buy

USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | April 27, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7113 seconds.